MARK4 and cancer: Aberrant expression or dysregulation of MARK4 is linked with the development of a variety of diseases including different types of cancer like hepatocellular carcinoma, glioma and metastatic breast carcinomas4,13,14, neurological disorders like Alzheimer’s disease3, metabolic disorders including diet-induced obesity, cardiovascular diseases and type-II diabetes12,15.